Loss of Consciousness and Visual Hallucinations Related to 5-MeO-DALT Intake, a Case Report Confirmed by Toxicological Analyses.
Journal of analytical toxicology – August 13, 2022
Source: PubMed
Summary
A 46-year-old man experienced a brief loss of consciousness and visual hallucinations after taking three 5-MeO-DALT tablets, each containing 32.5 mg at 11% purity. Blood samples revealed a plasma concentration of 7 ng/mL, taken eight hours post-consumption. Cases of 5-MeO-DALT poisoning are uncommon, yet the increasing accessibility of such substances highlights the need for emergency department physicians and toxicologists to remain vigilant. Standard toxicological screenings often fail to detect these recreational tryptamines, posing potential risks for patients.
Abstract
5-MeO-DALT or 5-methoxy-N,N-diallyltryptamine is a derivative of tryptamines, consumed for its hallucinogenic and entheogenic effects. We report the case of a 46-year-old-man, presenting with a brief loss of consciousness and visual hallucinations, after the consumption of three 5-MeO-DALT tablets bought online. Liquid chromatography coupled to tandem mass spectrometry method was performed, and 5-MeO-DALT was quantified in both the tablets (32.5 mg per tablet, 11% of purity) and the patient's plasma (7 ng/mL-8 h between the consumption and the blood sample). 5-MeO-DALT poisonings are rarely described. Given the broad availability of these products, it is important that emergency department physicians and clinical toxicologists do not overlook the possibility of the ingestion of recreational tryptamines, especially since they are not detected by most routine toxicological screening.